APA (7th ed.) Citation

KG, M., B, G., SS, H., D, B., CE, G., KM, T., . . . JS, T. (2023). High-volume hybridoma sequencing on the NeuroMabSeq platform enables efficient generation of recombinant monoclonal antibodies and scFvs for neuroscience research. Scientific reports, 13(1), 16200. https://doi.org/10.1038/s41598-023-43233-4

Chicago Style (17th ed.) Citation

KG, Mitchell, et al. "High-volume Hybridoma Sequencing on the NeuroMabSeq Platform Enables Efficient Generation of Recombinant Monoclonal Antibodies and ScFvs for Neuroscience Research." Scientific Reports 13, no. 1 (2023): 16200. https://doi.org/10.1038/s41598-023-43233-4.

MLA (9th ed.) Citation

KG, Mitchell, et al. "High-volume Hybridoma Sequencing on the NeuroMabSeq Platform Enables Efficient Generation of Recombinant Monoclonal Antibodies and ScFvs for Neuroscience Research." Scientific Reports, vol. 13, no. 1, 2023, p. 16200, https://doi.org/10.1038/s41598-023-43233-4.